Chronic myelogenous leukemia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Chronic myelogenous leukemia
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Fatigue, weight loss, fever, night sweats, splenomegaly
Complications	Blast crisis, anemia, thrombocytopenia
Onset	Typically in adulthood
Duration	Chronic
Types	N/A
Causes	Philadelphia chromosome (translocation between chromosome 9 and chromosome 22)
Risks	Radiation exposure, age, male gender
Diagnosis	Complete blood count, bone marrow biopsy, cytogenetic analysis
Differential diagnosis	Chronic lymphocytic leukemia, acute myeloid leukemia, myeloproliferative neoplasms
Prevention	N/A
Treatment	Tyrosine kinase inhibitors, chemotherapy, stem cell transplant
Medication	N/A
Prognosis	Generally good with treatment
Frequency	1-2 cases per 100,000 people per year
Deaths	N/A

Schematic of the Philadelphia Chromosome

Diagram showing which cells CML can start in CRUK 388.svg

LMC4

Chronic Myeloid Leukemia smear 2009-04-09

Hypolobated small megakaryocyte

Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a type of cancer that originates in the bone marrow and results in the overproduction of white blood cells. It is a form of leukemia, which is a group of cancers that typically begin in the bone marrow and result in high numbers of abnormal white blood cells.

Pathophysiology

CML is characterized by the presence of the Philadelphia chromosome, a specific genetic abnormality in chromosome 22 of human cells. This abnormality is a result of a translocation between chromosome 9 and chromosome 22, which creates the BCR-ABL fusion gene. The BCR-ABL gene produces a protein with tyrosine kinase activity that leads to uncontrolled cell division.

Symptoms

Common symptoms of CML include:

• Fatigue
• Weight loss
• Night sweats
• Fever
• Splenomegaly (enlarged spleen)
• Hepatomegaly (enlarged liver)
• Bone pain

Diagnosis

CML is typically diagnosed through a combination of blood tests, bone marrow biopsy, and cytogenetic analysis. The presence of the Philadelphia chromosome is a key diagnostic marker.

Stages

CML progresses through three phases:

• Chronic phase: The disease progresses slowly and patients may have mild symptoms.
• Accelerated phase: The disease progresses more rapidly and symptoms become more severe.
• Blast crisis: The disease behaves like an acute leukemia with rapid progression and severe symptoms.

Treatment

Treatment options for CML include:

• Tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, and nilotinib.
• Chemotherapy
• Stem cell transplant
• Interferon therapy

Prognosis

The prognosis for CML has improved significantly with the advent of tyrosine kinase inhibitors. Many patients achieve long-term remission and have a normal life expectancy.

Epidemiology

CML accounts for about 15-20% of all cases of adult leukemia. It is more common in older adults, with the median age at diagnosis being around 65 years.

See also

• Leukemia
• Bone marrow
• Philadelphia chromosome
• Tyrosine kinase inhibitors